Female Pattern Alopecia: Its Importance in Medicine and Aesthetic Surgery
June 2020
in “
Medicina estética (Madrid)
”
TLDR Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.
The study "Alopecia con patrón femenino. Su importancia en medicina y cirugía estética" from June 15, 2020, investigated female pattern hair loss (FPHL), a common condition affecting 29% to 38% of pre-menopausal women and over 55% of women over 70. The cause of FPHL is believed to be multifactorial, with hormonal and genetic factors playing a significant role. The study emphasized the importance of early diagnosis and treatment to prevent progression, with topical Minoxidil being the only FDA-approved treatment at the time. The document also explored various other treatments, including low-intensity laser treatment, Finasteride, Dutasteride, and others, but concluded that more double-blind randomized studies are needed to establish their effectiveness. The psychological impact of FPHL, including anxiety, depression, and low self-esteem, was also highlighted.